Jiping Zha
Corporate Officer/Principal presso ADAGENE INC.
Profilo
Jiping Zha is currently the Executive Vice President-Clinical Development at Adagene, Inc. Prior to this, he worked as the Executive Director-Translational Sciences at NGM Biopharmaceuticals, Inc. from 2017 to 2021.
He also held positions at Crown Bioscience, Inc. as the Senior Vice President-Drug Discovery Technology, and at The University of Texas Southwestern Medical Center and Harvard Medical School as an Assistant Professor.
Dr. Zha received his doctorate from Zhongshan Hospital Fudan University in 1987 and from The University of Tennessee Health Science Center in 1993.
Posizioni attive di Jiping Zha
| Società | Posizione | Inizio |
|---|---|---|
| ADAGENE INC. | Corporate Officer/Principal | 01/09/2021 |
Precedenti posizioni note di Jiping Zha
| Società | Posizione | Fine |
|---|---|---|
| NGM BIOPHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/09/2021 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | - |
| Harvard Medical School | Corporate Officer/Principal | - |
| The University of Texas Southwestern Medical Center | Corporate Officer/Principal | - |
Crown Bioscience, Inc.
 Crown Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Crown Bioscience, Inc. provides biomedical outsourcing solutions. It provides syngeneic and xenograft tumor models and custom model development and drug testing. The firm produces antibodies for therapeutic, diagnostic and theranostic applications. It also offers preclinical and drug development for anti-cancers therapeutics. The company was founded by Dr. Yiyou Chen, Dr. Yue Alexander Wu, Dr. William Pan and Dr. Faming Zhang in 2006 and is headquartered in Santa Clara, CA. | Corporate Officer/Principal | - |
Formazione di Jiping Zha
| Zhongshan Hospital Fudan University | Doctorate Degree |
| The University of Tennessee Health Science Center | Doctorate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| ADAGENE INC. | Health Technology |
| NGM BIOPHARMACEUTICALS, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
Crown Bioscience, Inc.
Crown Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Crown Bioscience, Inc. provides biomedical outsourcing solutions. It provides syngeneic and xenograft tumor models and custom model development and drug testing. The firm produces antibodies for therapeutic, diagnostic and theranostic applications. It also offers preclinical and drug development for anti-cancers therapeutics. The company was founded by Dr. Yiyou Chen, Dr. Yue Alexander Wu, Dr. William Pan and Dr. Faming Zhang in 2006 and is headquartered in Santa Clara, CA. | Commercial Services |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
- Borsa valori
- Insiders
- Jiping Zha
